David Sidransky

Insider Reports History

Entity
Individual
Location
Johns Hopkins University, 720 Rutland Avenue, Baltimore, MD
Signature
/s/ David Sidransky
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Sidransky:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CHAMPIONS ONCOLOGY, INC. Director Option to purchase Common Stock 21.9K $102K $4.64 Nov 12, 2024 Direct
Ayala Pharmaceuticals, Inc. Director Common Stock 93 $37.20 $0.40 Jan 19, 2023 Direct
Ayala Pharmaceuticals, Inc. Director Common Stock 46 $18.40 $0.40 Jan 19, 2023 Held by Reporting Person's Son
Orgenesis Inc. Director Stock Option 20.5K Dec 20, 2023 Direct
Ayala Pharmaceuticals, Inc. Director Stock Option 2.34K Jan 19, 2023 Direct
Old Ayala, Inc Director Common Stock 0 Jan 19, 2023 Held by Reporting Person's son
Old Ayala, Inc Director Stock Option (right to buy) 0 Jan 19, 2023 Direct

Insider Reports Filed by David Sidransky

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CSBR CHAMPIONS ONCOLOGY, INC. Nov 12, 2024 1 $102K 4 Nov 18, 2024 Director
ORGS Orgenesis Inc. Dec 20, 2023 1 $0 4 Dec 21, 2023 Director
CSBR CHAMPIONS ONCOLOGY, INC. Nov 3, 2023 1 $85.4K 4 Nov 7, 2023 Director
AYLA Old Ayala, Inc Jan 19, 2023 3 $0 4 Jan 23, 2023 Director
ADXS Ayala Pharmaceuticals, Inc. Jan 19, 2023 3 $0 4 Jan 23, 2023 Director
ORGS Orgenesis Inc. Dec 23, 2022 1 $0 4 Dec 29, 2022 Director
CSBR CHAMPIONS ONCOLOGY, INC. Nov 1, 2022 1 $80.4K 4 Aug 17, 2023 Director
CSBR CHAMPIONS ONCOLOGY, INC. Oct 12, 2022 3 -$2 4 Oct 14, 2022 Director
AYLA Ayala Pharmaceuticals, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
ORGS Orgenesis Inc. Dec 31, 2021 1 $0 5 Feb 14, 2022 Director
CSBR CHAMPIONS ONCOLOGY, INC. Nov 5, 2021 1 $81.3K 4 Nov 9, 2021 Director
CCTS Cactus Acquisition Corp. 1 Ltd Oct 28, 2021 0 $0 3 Nov 4, 2021 Director
CSBR CHAMPIONS ONCOLOGY, INC. Oct 15, 2021 3 $53K 4 Oct 19, 2021 Director
AYLA Ayala Pharmaceuticals, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director